ETV6 gene rearrangements in hematopoietic malignant disorders

Leukemia and Lymphoma

Volumn 23, Issue 3-4, 1996, Pages 287-295

  Wlodarska, Iwona ^a   Mecucci, Cristina ^b   Baens, Mathijs ^a   Marynen, Peter ^a   Van Den Berghe, Herman ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PERUGIA   (Italy)

^c CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

ETV6 TEL; Gene fusion; Leukemia

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 12; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; EXON; GENE REARRANGEMENT; GENE STRUCTURE; LYMPHATIC LEUKEMIA; MYELOID LEUKEMIA; MYELOMONOCYTIC LEUKEMIA; PRIORITY JOURNAL; REVIEW;

EID: 0030464979     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054831     Document Type: Review

References (54)

1. Golub, T. R., Barker, G. F., Lovett, M. and Gilliland, D. G. (1994) Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307-316.
2. Buijs, A., Sherr, S., van Baal, S., van Bezouw, S., van der Plas, D., Geurts van Kessel, A., Riegman, P., Lekanne Deprez, R., Zwarthoff, E., Hagemeijer, A. and Grosveld, G. (1995) Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene in 22q11. Oncogene, 10, 1511-1519.
3. Papadopoulos, P., Ridge, S. A., Boucher, C. A., Stocking, C. and Wiedemann, L. M. (1995) The novel activation of ABL by fusion to an ets-related gene. TEL. Cancer Research, 55, 34-38.
4. Golub, T. R., Barker, G. F., Bohlander, S. K., Hieben, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D. and Gilliland, D. G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Science USA, 92, 4917-4921.
5. Romana, S. P., Mauchauffe, M., Leconiat, M., Chumakov, I., Le Paslier, D., Berger, R. and Bernard, O. A. (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85, 3662-3670.
6. Rabbitts, T. H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
7. Mitelman, F. (1994) Catalog of Chromosome Aberrations in Cancer, 5th ed. New York: Wiley-Liss.
8. Raimondi, S C., Williams, D. L., Callihan, T., Peiper, S., Rivera, G. K. and Murphy, S. B. (1986) Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymhoblastic leukemia. Blood, 68, 69-75.
9. Raimondi, S. C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81, 2237-2251.
10. Kobayashi, H., Montgomery, K. T., Bohlander, S. K., Adra, C. N., Lim, B. L., Kucherlapati, R. S., Donis-Keller, H., Holt, M. S., Le Beau, M. M. and Rowley, J. D. (1994) Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood, 84, 3473-3482
11. Sato, Y., Suto, Y., Pietenpol, J., Golub, T. R., Gilliland, G , Davis, E. M., Le Beau, M M., Roberts, J. M., Vogelstein, B., Rowley, J. D. and Bohlander, S. K. (1995) TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood, 86, 1525-1533.
12. Hoglund, M., Johansson, B., Pedersen-Bjergaard, J., Marynen, P. and Mitelman, F. (1996) Molecular characterization of 12p abnormalities in hematologic malignancies. Deletion of KIP1, rearrangement of TEL and amplification of cyclin D2. Blood, 87, 324-330.
13. Wlodarska, I., Marynen, P., La Starza, R., Mecucci, C. and Van den Berghe, H. (1996) The TEL, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberrations in different hematological malignancies. Cytogenetics and Cell Genetics, 72, 229-235.
14. Baens, M., Peeters, P., Guo, C., Aerssens, J. and Marynen, P. (1996) The genomic organisation of the human ETS-variant gene 6 (ETV6). Genome Research, in press.
15. Wessels, J W., Fibbe, W. E., van der Keur, D., Landegent, J. E., van der Plas, D. C., den Ottolander, G. J., Roozendaal, K. J. and G. C., Beversrock (1993) t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics, 65, 7-11.
16. Baranger, L., Szapiro, N., Gardais, J., Hillion, J., Derre, J., François, S., Blanchet, O , Boasson, M. and Berger, R. (1994) Translocation t(5,12)(q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia British Journal of Haemaology, 88, 343-347
17. Wlodarska, I., Mecucci, C., Marynen, P., Guo, C . Franckx, D., La Starza. R., Aventin, A., Bosly, M. F., Martelli, J. J., Cassiman, J. J. and Van den Berghe, H. (1995) TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) or its variant t(10;12)(q24;p13). Blood, 85, 2848-2852.
18. Raynaud, S. D , Baens, M., Parganas, E., Grosgeorge, J., Nucifora, G., Rodgers, K., Dainton, M., Ayraud, N. and Marynen, P. (1995) t(3,12)(q26;p13): A recurring chromosomal abnormality in RAEBT and CML in acute transformation. G00-682-371.
19. Wlodarska, I., Marynen, P., La Starza, R., Mecucci, C., Uyttebroek, A., Verhoef, G. and Van den Berghe, H. (1995) TEL rearrangements in a childhood acute leukemias associated with a t(7;12)(p15;p13) Abstract. ASH 37th Annual Meeting, Seattle, Washington, December 1-5, 1995. Blood, 86, no. 10, Suppl 1, 787a.
20. Lekanne Deprez, R. H., Riegman, P. H., Groen, N. A., Warringa, U. L., van Biezen, N. A., Molijn A. C., Bootsma, D., de Jong, P. J., Menon, A. G., Kley, N. A., Seizinger, B. R. ane Zwathoff, E. C. (1995) Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene, 20, 1521-1528.
21. Gerber, H. P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S. and Schaffner, W. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science, 263, 808-811.
22. Westbrook, C. A., Hooberman, A. L., Spino, C., Dodge, R. K., Larson, R. A., Davey, F., Wurster-Hill, D. H., Sobol, R. E., Schiffer, C. and Bloomfield, C. D. (1992) Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood, 80, 2983-2990.
23. Golub, T. R., Barker, G. F., Bohlander, S. K., Stesmaier, K., Bray-Ward, P., Ward, D. C , Sato, Y., Suto, Y., Rowley, J. D. and Gilliland, D. G. (1994) Evidence implicating the TEL gene at 12p13 in multiple mechanisms of leukemogenesis. Abstract. ASH 36th Annual Meeting, Nashville, December 2-6. Blood, 84, no. 10, Suppl 1, 451a.
24. Brunel, V., Lafage-Pochitaloff, M., Carbuccia, N., Sainty, D., Costello, R T., Gabert, J., Simonetti, J., Coignet, L., Dubreuil, P. and Birg, F. (1995) Translocation of c-ABL to chromosome 12p creates a new TEL/ABL fusion gene in a Philadelphia-negative chronic myeloid leukemia. G00-682-383.
25. Janssen, J W. G., Ridge, S. A., Papadopoulos, P., Cotter, F., Ludwig, W.-D., Fonatsch, C., Rieder, H., Ostertag, W., Bartram, C. R. and Wiedemann, L. M (1995) The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. British Journal of Haematology, 90, 222-224.
26. Beverloo, H. B., Le Coniat, M., Wijsman, J., Lillington, D. M., Bernard, O., de Klein, A., van Wering, E., Welborn, J., Young, B. D., Hagemeijer, A and Berger, R. (1995) Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Research, 55, 4220-4224.
27. Romana, S. P., Le Coniat, M. and Berger, R. (1994) t(12;21): A new recurrent translocation in acute lymphoblastic leukemia Genes, Chromosomes & Cancer, 9, 186-191.
28. Nucifora, G. and Rowley, J. D. (1995) AML1 and the 8:21 and 3:21 translocations in acute and chronic myeloid leukemia. Blood, 86, 1-14.
29. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. and Ohki, M. (1991) The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proceedings of the National Academy of Science USA, 88, 10431-10434.
30. Nisson, P. E., Watkins, P. C. and Sacchi, N. (1992) Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in the t(8;21) leukemic cells. Cancer Genetics and Cytogenetics, 63, 81-88.
31. Erickson, P., Gao, J., Chang, K.-S., Look, T., Whisenant, E., Raimondi, S., Lasher, R , Trujillo, J., Rowley, J. D. and Drabkin, H. (1992) Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood, 80, 1825-1831.
32. Nucifora, G., Begy, C. R., Erickson, P , Drabkin, H. A. and Rowley, J. D. (1993) The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER-1. Proceedings of the National Academy of Science USA, 90, 7784-7788
33. Nucifora, G., Begy, C. R., Kobayashi, H., Claxton, D., Pedersen-Bjergaard, J., Parganas, E , Ihle, J. and Rowley, J. D. (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in the (3;21)(q26;q22) translocation. Proceedings of the National Academy of Science USA, 91, 4004-4008.
34. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M. K., Mano, H., Yazaki, Y., Ohki, M. and Hirai, H. (1994) Generation of the AML1/EVI1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO Journal, 13, 504-510.
35. Raynaud, S., Cavé, H., Baens, M., Bastard, C., Cacheux, V., Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P. and deletion of the other TEL and Grandchamp, B. (1996) The 12;21 translocation involving TEL allele: two frequently associated alterations found in childhood acute lymphoblastyic leukemia. Blood, 87, 2891-2899.
36. Wlodarska, I., Baens, M., Peeters, P., Aerssens, J., Mecucci, C., Brock, P., Marynen, P. and Van den Berghe, H. (1996) Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood ALL case Cancer Research, in press.
37. Romana, S. P , Poirel, H., Leconiat, M., Flexor, M.-A., Mauchauffé, M., Jonveaux, P., Macintyre, E. A., Berger, R. and Bernard, O. A. (1995) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
38. Stegmaier, K., Pendse, S., Barker, G. F., Bray-Ward, P., Ward, D. C., Montgomery, K. T., Krauter, K. S., Reynolds, C., Sklar, J., Donelly, M., Bohlander, S. K., Rowley, J. D., Sallan, S. E., Gilliland, D. G. and Golub, T. R. (1995) Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood, 86, 38-44.
39. KIP1. Blood, 86, 3869-3875.
40. Romana, S. P., Le Coniat, M., Poirel, H., Marynen, P., Bernard, O. A. and Berger, R. (1995) Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia, 10, 167-170
41. Shurtleff, S. A., Buijs, A., Behm, F G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G. C.-F., Pui, C-H , Grosveld, G. and Downing, J. R. (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis Leukemia, 9, 1985-1989.
42. Buijs, A., Vertegaal, A C. O., Molijn, A., Zwarthoff, E. C., Davis, N., Roussel, M. F. and Grosveld, G. C. (1995) MN1-TEL fusion protein, associated with t(12;22) in myeloid proliferative disorders, transforms NIH3T3 ceils and is located in clusters in the nucleus and cytoplasm. G00-682-384.
43. Gilliland, D. G., Golub, T., Barker, G., Bohlander, S., Rowley, J., Afar, D., Goga, A. and Witte, O. (1995) Characterization of the TEL-PDGFRβ and TEL-ABL fusion proteins associated with human leukemias. G00-682-393.
44. Hannemann, J. R., Kabarowski, J. H. S., Ridge, S. A., Papadopoulos, P. and Wiedemann, L. M. (1995) The TEL/ABL fusion protein as a model for the activation of ABL. G00-682-394.
45. Heldin, C.-H., Ernlund, A., Rorsman, C. and Ronnstrand, L. (1989) Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. Journal of Biological Chemistry, 264, 8905-8912.
46. Sawyers, C. L. and Denny, C. T. (1994) Chronic myelomonocytic leukemia: Tel-a-Kinase what Ets all about. Cell, 77, 171-173.
47. McWhirter, J R., Galasso, D. L. and Wang, J. Y. J. (1993) A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Molecular Cell Biology, 13, 7587-7595.
48. Bailly, R. A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G. and Ghysdael, J. (1994) DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11,22) translocation in Ewing sarcoma. Molecular Cell Biology, 14, 3230-3241.
49. Johansson, B., Mertens, F. and Mitelman, F. (1993) Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor loci. Genes, Chromosomes & Cancer, 8, 205-218.
50. Kobayashi, H. and Rowley, J. D. (1995) Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization. Genes Chromosom. Cancer, 12, 66-69.
51. KIP1, a Cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-68.
52. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 Cyclin-CdK protein kinase activity, is related to p21. Cell, 78, 67-74.
53. KIp1 gene to 12p13 and its analysis in leukemias. Cancer Research, 55, 1206-1210.
54. Merlo, A., Herman, J G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidranksy, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 1, 686-692.